N-(1-methyl-5-indolyl)-N'-(3-methyl-5-isothiazolyl)urea: a novel, high-affinity 5-HT2B receptor antagonist.
Autor: | Forbes IT; SmithKline Beecham Pharmaceuticals, Discovery Research, Harlow, Essex, England., Jones GE, Murphy OE, Holland V, Baxter GS |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of medicinal chemistry [J Med Chem] 1995 Mar 17; Vol. 38 (6), pp. 855-7. |
DOI: | 10.1021/jm00006a001 |
Databáze: | MEDLINE |
Externí odkaz: |